Wonbiogen Co., Ltd. (KOSDAQ:307280)

Wonbiogen Revenue

Wonbiogen had revenue of 9.93B KRW in the quarter ending June 30, 2026, with 18.26% growth. This brings the company's total for the last twelve months to 37.80B, up 18.04% year-over-year. In the year 2025, Wonbiogen had annual revenue of 35.24B with 15.78% growth. That makes Wonbiogen the 31,646th largest company in the world by revenue and 2,005th in South Korea.

• Revenue (ttm): 37.80B
• Revenue Growth: +18.04%
• P/S Ratio: 1.02
• Revenue / Employee: 466.71M
• Employees: 81
• Market Cap: 38.59B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Wound Dressing 31.10B 87.2%
• Household goods 4.55B 12.8%

By Geography

Chart

• South Korea 30.06B 85.3%
• Asia 4.72B 13.4%
• Europe 354.30M 1.0%
• Other 101.17M 0.3%

Fiscal year ended Dec 31, 2025 See the full Wonbiogen breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	35.24B	4.80B	15.78%
Dec 31, 2024	30.44B	824.93M	2.79%
Dec 31, 2023	29.61B	2.87B	10.72%
Dec 31, 2022	26.75B	9.03B	50.94%
Dec 31, 2021	17.72B	5.70B	47.46%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 21, 2026

Data Sources Report a data error